554 related articles for article (PubMed ID: 25975262)
1. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
3. miR-193a-3p inhibition of the Slug activator PAK4 suppresses non-small cell lung cancer aggressiveness via the p53/Slug/L1CAM pathway.
Liu X; Min S; Wu N; Liu H; Wang T; Li W; Shen Y; Zhao C; Wang H; Qian Z; Xu H; Chen Y; Wang X
Cancer Lett; 2019 Apr; 447():56-65. PubMed ID: 30685413
[TBL] [Abstract][Full Text] [Related]
4. Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer.
Chen B; Tan Z; Gao J; Wu W; Liu L; Jin W; Cao Y; Zhao S; Zhang W; Qiu Z; Liu D; Mo X; Li W
J Exp Clin Cancer Res; 2015 Oct; 34():126. PubMed ID: 26490682
[TBL] [Abstract][Full Text] [Related]
5. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
[TBL] [Abstract][Full Text] [Related]
6. p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretion.
Lu W; Xia YH; Qu JJ; He YY; Li BL; Lu C; Luo X; Wan XP
Neoplasma; 2013; 60(5):493-503. PubMed ID: 23790167
[TBL] [Abstract][Full Text] [Related]
7. DGCR6L, a novel PAK4 interaction protein, regulates PAK4-mediated migration of human gastric cancer cell via LIMK1.
Li X; Ke Q; Li Y; Liu F; Zhu G; Li F
Int J Biochem Cell Biol; 2010 Jan; 42(1):70-9. PubMed ID: 19778628
[TBL] [Abstract][Full Text] [Related]
8. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
[TBL] [Abstract][Full Text] [Related]
9. p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation.
Siu MK; Kong DS; Ngai SY; Chan HY; Jiang L; Wong ES; Liu SS; Chan KK; Ngan HY; Cheung AN
PLoS One; 2015; 10(7):e0133467. PubMed ID: 26218748
[TBL] [Abstract][Full Text] [Related]
10. A two kinase-gene signature model using CDK2 and PAK4 expression predicts poor outcome in non-small cell lung cancers.
Wang X; Lu Y; Feng W; Chen Q; Guo H; Sun X; Bao Y
Neoplasma; 2016; 63(2):322-9. PubMed ID: 26774155
[TBL] [Abstract][Full Text] [Related]
11. Activated Pak4 expression correlates with poor prognosis in human gastric cancer patients.
Li D; Zhang Y; Li Z; Wang X; Qu X; Liu Y
Tumour Biol; 2015 Dec; 36(12):9431-6. PubMed ID: 26124003
[TBL] [Abstract][Full Text] [Related]
12. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
[TBL] [Abstract][Full Text] [Related]
13. PAK4 expression is associated with the prognosis in non-small cell lung cancer.
Li C; Ji D; Duan A; Jiang Q
Medicine (Baltimore); 2022 Aug; 101(33):e30050. PubMed ID: 35984204
[TBL] [Abstract][Full Text] [Related]
14. Membranous expression of activated leukocyte cell adhesion molecule contributes to poor prognosis and malignant phenotypes of non-small-cell lung cancer.
Ishiguro F; Murakami H; Mizuno T; Fujii M; Kondo Y; Usami N; Taniguchi T; Yokoi K; Osada H; Sekido Y
J Surg Res; 2013 Jan; 179(1):24-32. PubMed ID: 22985775
[TBL] [Abstract][Full Text] [Related]
15. High NUAK1 expression correlates with poor prognosis and involved in NSCLC cells migration and invasion.
Chen P; Li K; Liang Y; Li L; Zhu X
Exp Lung Res; 2013 Feb; 39(1):9-17. PubMed ID: 23215946
[TBL] [Abstract][Full Text] [Related]
16. Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma.
Zhang HJ; Siu MK; Yeung MC; Jiang LL; Mak VC; Ngan HY; Wong OG; Zhang HQ; Cheung AN
Carcinogenesis; 2011 May; 32(5):765-71. PubMed ID: 21325635
[TBL] [Abstract][Full Text] [Related]
17. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
[TBL] [Abstract][Full Text] [Related]
18. A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF.
Ahmed T; Shea K; Masters JR; Jones GE; Wells CM
Cell Signal; 2008 Jul; 20(7):1320-8. PubMed ID: 18424072
[TBL] [Abstract][Full Text] [Related]
19. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
20. Expression of Ras-related protein 25 predicts chemotherapy resistance and prognosis in advanced non-small cell lung cancer.
Ma YF; Yang B; Li J; Zhang T; Guo JT; Chen L; Li M; Chu J; Liang CY; Liu Y
Genet Mol Res; 2015 Oct; 14(4):13998-4008. PubMed ID: 26535714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
